… strong association between circulating free DNA in patients being treated with olaparib (Lynparza) for prostate cancer and disease outcome. … Late-stage studies with the drug have seen also improved outcomes in breast cancer.

adminRecent... strong association between circulating free DNA in patients being treated with olaparib (Lynparza) for prostate cancer and disease outcome. ... Late-stage studies with the drug have seen also improved outcomes in breast cancer.Breast Cancer Research Updates From Around the Web